Deracoxib

DB11395ExperimentalVet approvedSmall molecule

Deracoxib is a non-steroidal anti-inflammatory drug of the coxib class, used in veterinary medicine to treat osteoarthritis in dogs. It is sold in tablets, which have added beefy flavour to... Deramaxx received FDA approval in August 2002 for "the control of post operative pain and inflammation associated with orthopedic surgery in dogs.

Mechanism: Pharmacologically active on Prostaglandin G/H synthase 2
Curator reviewed
Formula / weight: C₁₇H₁₄F₃N₃O₃S · 397.37 g/mol (avg)
Code names: SC 046 · SC-59046

Resolves to

Compound

UNIIVX29JB5XWVCAS169590-41-4ChEMBLCHEMBL28636ChEBI73032KEGGD03689

Clinical / RWD

RxNorm356834

Structure

InChIKeyWAZQAZKAZLXFMK-UHFFFAOYSA-NSMILESCOC1=C(F)C=C(C=C1)C1=CC(=NN1C1=CC=C(C=C1)S(N)(=O)=O)C(F)F

Targets

Q8SPQ9Prostaglandin G/H synthase 2P35354PTGS2

What you can answer from here — as of July 07, 2026

3Protein targetsEach mapped to UniProt, with action and pharmacological action

Listed above

15+ReferencesStructured and connected to the statements they support

Which drugs share a target with Deracoxib, and which of those have an active Phase 3 trial?

Answer this in Biopharma OS Sign in to your account

Create a free account or log in to explore the full data card.

Create Account